NO950716L - Nye substituerte sulfonamider - Google Patents
Nye substituerte sulfonamiderInfo
- Publication number
- NO950716L NO950716L NO950716A NO950716A NO950716L NO 950716 L NO950716 L NO 950716L NO 950716 A NO950716 A NO 950716A NO 950716 A NO950716 A NO 950716A NO 950716 L NO950716 L NO 950716L
- Authority
- NO
- Norway
- Prior art keywords
- substd
- formula
- new substituted
- substituted sulfonamides
- opt
- Prior art date
Links
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 229940124530 sulfonamide Drugs 0.000 title 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
- C07C2603/66—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9402159A FR2716679B1 (fr) | 1994-02-25 | 1994-02-25 | Nouvelles sulfonamides substituées, leur procédé de préparation et les compositions pharmaceutiques les renfermant. |
| US08/393,452 US5565457A (en) | 1994-02-25 | 1995-02-23 | Substituted sulfonamides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO950716D0 NO950716D0 (no) | 1995-02-24 |
| NO950716L true NO950716L (no) | 1995-08-28 |
| NO302571B1 NO302571B1 (no) | 1998-03-23 |
Family
ID=26230972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO950716A NO302571B1 (no) | 1994-02-25 | 1995-02-24 | Nye substituerte sulfonamider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5565457A (no) |
| EP (1) | EP0669322B1 (no) |
| JP (1) | JPH07258217A (no) |
| CN (1) | CN1053895C (no) |
| AT (1) | ATE184597T1 (no) |
| AU (1) | AU682428B2 (no) |
| CA (1) | CA2143249C (no) |
| DE (1) | DE69512104T2 (no) |
| DK (1) | DK0669322T3 (no) |
| ES (1) | ES2139156T3 (no) |
| FI (1) | FI110364B (no) |
| FR (1) | FR2716679B1 (no) |
| GR (1) | GR3031256T3 (no) |
| NO (1) | NO302571B1 (no) |
| NZ (1) | NZ270567A (no) |
| ZA (1) | ZA951577B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
| FR2804429B1 (fr) * | 2000-01-31 | 2003-05-09 | Adir | Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1366015A4 (en) * | 2001-03-01 | 2008-03-26 | Tech Resources Pty Ltd | BENZENE-1 2-DIOL MANNICH BASES, LIGANDS, POLYMERS, AND SELECTIVE METAL ION REMOVAL METHOD |
| US20040266732A1 (en) * | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
| EP1616862A4 (en) * | 2003-04-18 | 2008-07-16 | Ono Pharmaceutical Co | HETEROCYCLIC NITROGEN COMPOUND AND USE THEREOF |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3527768A (en) * | 1967-11-24 | 1970-09-08 | Monsanto Co | Sulfonamido coumarin compounds |
| JP2556722B2 (ja) * | 1988-02-18 | 1996-11-20 | 興和株式会社 | 新規なスルホンアミド化合物 |
| US5032604A (en) * | 1989-12-08 | 1991-07-16 | Merck & Co., Inc. | Class III antiarrhythmic agents |
| WO1992014712A1 (en) * | 1991-02-13 | 1992-09-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Substituted sulfonamide derivative or pharmaceutical composition containing the same |
-
1994
- 1994-02-25 FR FR9402159A patent/FR2716679B1/fr not_active Expired - Fee Related
-
1995
- 1995-02-22 FI FI950818A patent/FI110364B/fi not_active IP Right Cessation
- 1995-02-23 AT AT95400384T patent/ATE184597T1/de not_active IP Right Cessation
- 1995-02-23 EP EP95400384A patent/EP0669322B1/fr not_active Expired - Lifetime
- 1995-02-23 ES ES95400384T patent/ES2139156T3/es not_active Expired - Lifetime
- 1995-02-23 CA CA002143249A patent/CA2143249C/fr not_active Expired - Fee Related
- 1995-02-23 DK DK95400384T patent/DK0669322T3/da active
- 1995-02-23 DE DE69512104T patent/DE69512104T2/de not_active Expired - Fee Related
- 1995-02-23 AU AU13449/95A patent/AU682428B2/en not_active Ceased
- 1995-02-23 US US08/393,452 patent/US5565457A/en not_active Expired - Fee Related
- 1995-02-24 CN CN95102144A patent/CN1053895C/zh not_active Expired - Fee Related
- 1995-02-24 NO NO950716A patent/NO302571B1/no unknown
- 1995-02-24 JP JP7036490A patent/JPH07258217A/ja active Pending
- 1995-02-24 ZA ZA951577A patent/ZA951577B/xx unknown
- 1995-02-24 NZ NZ270567A patent/NZ270567A/en unknown
-
1999
- 1999-09-20 GR GR990402350T patent/GR3031256T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2143249A1 (fr) | 1995-08-26 |
| FI950818L (fi) | 1995-08-26 |
| DK0669322T3 (da) | 2000-03-27 |
| FR2716679A1 (fr) | 1995-09-01 |
| EP0669322B1 (fr) | 1999-09-15 |
| DE69512104D1 (de) | 1999-10-21 |
| FR2716679B1 (fr) | 1996-04-05 |
| DE69512104T2 (de) | 2000-04-20 |
| GR3031256T3 (en) | 1999-12-31 |
| FI950818A0 (fi) | 1995-02-22 |
| AU682428B2 (en) | 1997-10-02 |
| CN1053895C (zh) | 2000-06-28 |
| AU1344995A (en) | 1995-09-07 |
| ZA951577B (en) | 1995-12-12 |
| CA2143249C (fr) | 2002-02-26 |
| NZ270567A (en) | 1996-05-28 |
| NO950716D0 (no) | 1995-02-24 |
| NO302571B1 (no) | 1998-03-23 |
| FI110364B (fi) | 2002-12-31 |
| JPH07258217A (ja) | 1995-10-09 |
| ATE184597T1 (de) | 1999-10-15 |
| US5565457A (en) | 1996-10-15 |
| EP0669322A1 (fr) | 1995-08-30 |
| CN1120537A (zh) | 1996-04-17 |
| ES2139156T3 (es) | 2000-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2179071T3 (es) | Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada. | |
| DK0421364T3 (da) | Pleuromutiliner | |
| DE68913930D1 (de) | Serotonin- und Norepinephrin-Aufnahme-Inhibitoren. | |
| UA26427A (uk) | Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу | |
| ATE165334T1 (de) | Benzamide | |
| ES2248114T3 (es) | Derivados de sulfonamida farmaceuticamente activos. | |
| DK0759919T3 (da) | Azolidindioner som antihyperglykæmiske midler | |
| ATE203536T1 (de) | Imidazodiazepine | |
| FI900146A0 (fi) | Akrylaattifungisidi ja niiden käyttö | |
| NO962207L (no) | Nye alkoksyarylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| UY24010A1 (es) | Nuevos pirrolocarbazoles | |
| NO950716D0 (no) | Nye substituerte sulfonamider | |
| MY113518A (en) | Benzothiazolone derivatives | |
| CO4770955A1 (es) | Acidos 4-amino-2-heterobiciclo [3.1.0] hexano -4,6- dicarboxilicos | |
| EP0657450A4 (en) | INDAZOLSULFONYL URINE DERIVATIVE, USE AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION. | |
| ES8609304A1 (es) | Procedimiento para la obtencion de derivados de indol | |
| FI956151A0 (fi) | Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia | |
| ES2038159T3 (es) | Procedimiento para preparar derivados sustituidos de 2-aminoacetamida. | |
| PT96422A (pt) | Processo para a preparacao de derivados de piperidina e de pirrolidina uteis como agentes anticolinergicos | |
| BG60248B2 (en) | Process for the preparation of phenoxyethylamine derivatives | |
| ECSP930947A (es) | Sales de cefalosporina y procedimiento para su preparacion | |
| ECSP951506A (es) | Derivado triciclicos del pirazol case ran 4081/91 | |
| ECSP993005A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos |